[go: up one dir, main page]

ES2160592T3 - Reduccion de las lesiones tisulares debidas a la isquemia y la reperfusion. - Google Patents

Reduccion de las lesiones tisulares debidas a la isquemia y la reperfusion.

Info

Publication number
ES2160592T3
ES2160592T3 ES93901403T ES93901403T ES2160592T3 ES 2160592 T3 ES2160592 T3 ES 2160592T3 ES 93901403 T ES93901403 T ES 93901403T ES 93901403 T ES93901403 T ES 93901403T ES 2160592 T3 ES2160592 T3 ES 2160592T3
Authority
ES
Spain
Prior art keywords
reperfusion
ischemia
tissular
reduction
injuries due
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93901403T
Other languages
English (en)
Inventor
Gary T Elliott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Application granted granted Critical
Publication of ES2160592T3 publication Critical patent/ES2160592T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTA UN METODO DE INHIBIR TEJIDO DAÑADO EN ANIMALES DE SANGRE CALIENTE RELACIONADOS CON REPERFUSION DE TEJIDOS DESPUES EXTENSOS PERIODOS DE ISQUEMIA. EL METODO COMPRENDE TRATAMIENTO ANTES DE UN SUCESO DE ISQUEMIA PLANIFICADO O HASTA SEIS HORAS DESPUES DE UN SUCESO DE ISQUEMIA NO PLANIFICADO CON UNA CANTIDAD EFECTIVA DE MONOFOSFORILO LIPIDO A O MONOFOSFORILO LIPIDO A 3-DEACILADO. TAMBIEN SE DESCRIBEN COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO.
ES93901403T 1991-12-31 1992-12-07 Reduccion de las lesiones tisulares debidas a la isquemia y la reperfusion. Expired - Lifetime ES2160592T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/815,250 US5286718A (en) 1991-12-31 1991-12-31 Method and composition for ameliorating tissue damage due to ischemia and reperfusion

Publications (1)

Publication Number Publication Date
ES2160592T3 true ES2160592T3 (es) 2001-11-16

Family

ID=25217292

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93901403T Expired - Lifetime ES2160592T3 (es) 1991-12-31 1992-12-07 Reduccion de las lesiones tisulares debidas a la isquemia y la reperfusion.

Country Status (10)

Country Link
US (1) US5286718A (es)
EP (2) EP0660719B1 (es)
JP (1) JPH07503709A (es)
KR (1) KR0156597B1 (es)
AU (1) AU657037B2 (es)
DE (1) DE69232033T2 (es)
ES (1) ES2160592T3 (es)
NZ (1) NZ245448A (es)
WO (1) WO1993012778A1 (es)
ZA (1) ZA929709B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747296A (en) * 1992-05-11 1998-05-05 Corvas International, Inc. Method of detecting neutophil inhibitory factor mimics
AU6475796A (en) * 1995-05-31 1996-12-18 University Of Alabama At Birmingham Research Foundation, The Monoclonal and polyclonal antibodies against recombinant hum an xanthine oxidase, method for their use and a kit containi ng same
JP3604467B2 (ja) * 1995-09-27 2004-12-22 株式会社東芝 心筋のねじれ補正方法
US6348567B1 (en) * 1995-12-06 2002-02-19 Cv Molecular Therapeutics Inc. Peptides and their use to ameliorate cell death
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
WO1999020284A1 (en) * 1997-10-23 1999-04-29 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents
US6013640A (en) * 1998-08-21 2000-01-11 Ribi Immunochem Research, Inc. Phosphoglycolipid and methods for its use
US6699846B2 (en) * 2000-03-17 2004-03-02 Corixa Corporation Mono- and disaccharides for the treatment of nitric oxide related disorders
US20030105032A1 (en) * 2000-05-19 2003-06-05 Persing David H. Phophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
WO2006063091A2 (en) * 2004-12-06 2006-06-15 Ronald Freudenberger Use of oxypurinol as an inhibitor of anti-neoplastic agent-induced cardiotoxicity
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US8273361B2 (en) 2006-09-26 2012-09-25 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
LT2437753T (lt) 2009-06-05 2016-12-12 Infectious Disease Research Institute Sintetiniai gliukopiranozillipidų adjuvantai ir juos turinčios vakcinų kompozicijos
WO2012141984A1 (en) 2011-04-08 2012-10-18 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
US11490615B2 (en) 2011-06-09 2022-11-08 Lifeline Scientific, Inc. Assessing, maintaining and/or restoring viability of organs/tissues
LT2850431T (lt) 2012-05-16 2018-06-25 Immune Design Corp. Vakcinos, skirtos hsv-2
US20140278468A1 (en) 2013-03-15 2014-09-18 I.D. Therapeutics Llc Apparatus and method for optimizing treatment using medication compliance patterns and glucose sensor
US10420337B2 (en) 2013-03-15 2019-09-24 Lifeline Scientific, Inc. Transporter with a glucose sensor for determining viability of an organ or tissue
KR102039520B1 (ko) 2013-04-18 2019-11-01 이뮨 디자인 코포레이션 암 치료에 이용하기 위한 gla 단일요법
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
EP3402490B1 (en) * 2016-01-15 2022-06-01 The Children's Medical Center Corporation Therapeutic use of mitochondria and combined mitochondrial agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4976959A (en) * 1986-05-12 1990-12-11 Burroughs Wellcome Co. T-PA and SOD in limiting tissue damage
US4985241A (en) * 1986-11-21 1991-01-15 Cetus Corporation Therapeutic combination of free-radical scavenger and tumor necrosis factor
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation

Also Published As

Publication number Publication date
EP0660719A4 (en) 1995-03-02
WO1993012778A1 (en) 1993-07-08
JPH07503709A (ja) 1995-04-20
NZ245448A (en) 1997-08-22
EP1068869A2 (en) 2001-01-17
ZA929709B (en) 1993-06-14
AU657037B2 (en) 1995-02-23
US5286718A (en) 1994-02-15
DE69232033D1 (de) 2001-10-04
KR940703658A (ko) 1994-12-12
AU3272293A (en) 1993-07-28
KR0156597B1 (ko) 1998-11-16
EP0660719A1 (en) 1995-07-05
EP1068869A3 (en) 2002-10-09
DE69232033T2 (de) 2002-06-06
EP0660719B1 (en) 2001-08-29

Similar Documents

Publication Publication Date Title
ES2160592T3 (es) Reduccion de las lesiones tisulares debidas a la isquemia y la reperfusion.
KR900011476A (ko) 백신 제제
FI895693A7 (fi) Parantuneen liukoisuuden omaavia kantaja/lääkeainekoostumuksia ja menetelmä niiden valmistamiseksi
IT1104643B (it) Sistema terapeutico in forma di cerotto o simile per la somministrazione di clonidina per via transdermica e procedimento per la sua preparazione
FI892703A0 (fi) Maaperän muokkaamiseen tarkoitetussa peltojyrässä oleva laite
IT8867350A0 (it) Dispositivo di azionamento per pompe o simili
NO923684D0 (no) Fremgangsmaate for aa begrense nedoverrettet vekst i induserte hydrauliske frakturer
IT1245849B (it) Procedimento per rivelare la concentrazione di un ingrediente attivo in un sistema acquoso
FI915783A7 (fi) N-jodipropargyylioksikarbonyyliaminohappoesterit ja niiden johdannaiset sekä niiden käyttö antimikrobisina aineina
FI924313A7 (fi) Menetelmä ja laite lääkkeiden vapauttamiseksi iholle
MX9100091A (es) Aparato para la propagacion de transplantes en el cultivo de plantas
NO306762B1 (no) Anvendelse av lanolinderivater sammen med polyetylenglykoletere, blanding derav og transdermalt terapeutisk system
MX172943B (es) Formulacion farmaceutica
DK601888A (da) Anvendelse af 2-pyrimidinyl-1-piperazinderivater
IT1211635B (it) Metodo per aumentare il regime di crescita di animali e composizione in esso impiegata
DK0511991T3 (da) Farmaceutisk formulering
IT1152781B (it) Procedimento per piantare in filari ad intervalli regolari vegetali e/o paletti e macchina per l'attuazione di tale procedimento
ES2017803B3 (es) Procedimiento para el transporte de piezas empaquetadas conjuntamente sobre la via y dispositivo para ello
ATE107648T1 (de) 1-carbacephalosporin-antibiotika.
ATA58988A (de) Optisch aktive oxo-isoindolinylderivate
ATA106988A (de) Streckwerk fuer wenigstens eine faserlunte
BR8800979A (pt) Composicao reguladora do crescimento de plantas e utilizacao
IT1211796B (it) Procedimento per l'accrescimento di cristalli
ES293956Y (es) Dispositivo para el cultivo de plantas
PT88984A (pt) Processo para a preparacao de embonato de azelastina e de composicoes farmaceuticas que o contem como ingrediente activo

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 660719

Country of ref document: ES